Saturday 7 November 2026
Export CGNX’s income statement to Excel — free account
Cognex Corporation
CGNX Technology Scientific & Technical Instruments
Cognex Corporation’s revenue for fiscal 2025 (year ended December 2025) was $994.4 million, up 8.73% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +358.2%
- Free cash flow
- +20.6%
Quarter to September 2026, against a year earlier
47.78
0.28
+0.59%
Follow CGNX
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
52.14 | 56.97 | 68.97 | 42.00 |
P/S ratio |
6.08 | 7.79 | 11.13 | 9.07 | |
P/FCF ratio |
25.95 | 34.37 | 45.81 | 36.16 | |
P/Operating CF |
80.72 | 180.90 | 175.25 | 147.61 | |
P/B ratio |
4.05 | 5.52 | 7.44 | 5.93 | |
Price to Tangible BV |
5.90 | 7.93 | 10.24 | 8.02 | |
EV/Sales |
5.74 | 7.51 | 10.76 | 8.45 | |
EV/EBITDA |
29.64 | 34.83 | 43.93 | 35.67 | |
EV/Operating CF |
23.26 | 31.43 | 42.35 | 32.18 | |
EV/FCF |
24.50 | 33.12 | 44.29 | 33.70 | |
Quick Ratio |
2.64 | 2.47 | 2.87 | 3.99 | |
Current Ratio |
3.80 | 3.64 | 3.93 | 5.04 | |
Net Debt/EBITDA |
(7.96) | (4.42) | (4.38) | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.50 | 0.53 | 0.52 | 0.53 | |
Operating CF/Net income |
2.29 | 0.87 | 0.95 | 0.00 | |
Capex/Depreciation |
0.58 | (0.38) | (0.22) | 0.00 | |
Research and Development Expense of Revenue |
14.29% | 13.79% | 11.12% | 10.82% | |
Selling, General and Administrative Expense of Revenue |
37.48% | 35.03% | 30.17% | 27.77% | |
Intangible Assets out of Total Assets |
0.23 | 0.22 | 0.20 | 0.20 | |
Share Based Compensation of Revenue |
5.50% | 4.45% | 3.85% | 0.00% | |
Graham Net Nets |
0.03 | 0.02 | 0.02 | 0.06 | |
Graham Number |
11.74 | 13.11 | 15.17 | 18.23 | |
Earnings Yield |
1.92% | 1.76% | 1.45% | 2.38% | |
Free Cash Flow Yield |
3.85% | 2.91% | 2.18% | 2.77% | |
Revenue per Share |
1.50 | 1.61 | 1.74 | 1.86 | |
Operating CF per Share |
0.45 | 0.27 | 0.41 | 0.00 | |
Capex per Share |
0.02 | (0.02) | (0.01) | 0.00 | |
Free Cash Flow per Share |
0.47 | 0.25 | 0.40 | 0.00 | |
Cash per Share |
2.01 | 1.78 | 2.42 | 4.13 | |
Shareholders Equity per Share |
8.88 | 8.88 | 9.74 | 10.23 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.88 | 8.88 | 9.74 | 10.23 | |
Free Cash Flow |
79.01 | 42.34 | 67.62 | 103.78 | |
Working Capital |
513.70 | 500.86 | 633.85 | 923.12 | |
Capital Expenditures |
4.11 | (2.76) | (1.53) | (2.64) | |
Net Current Asset Value |
172.59 | 163.70 | 300.79 | 596.86 | |
EV/EBIT |
35.12 | 40.04 | 49.13 | 33.79 | |
Capex to Sales |
(0.02) | 0.01 | 0.01 | 0.00 | |
Price to Operating Income |
37.19 | 41.55 | 50.83 | 36.26 | |
| Other line items | |||||
Average Receivables |
145.04 | 165.95 | 200.09 | 185.67 | |
Average Payables |
44.12 | 51.43 | 53.67 | 60.09 | |
Average Inventory |
147.71 | 143.83 | 143.71 | 151.07 | |
Average Assets |
2,004.70 | 1,969.06 | 2,091.10 | 2,139.61 | |
Average Common Equity |
1,504.70 | 1,462.30 | 1,567.81 | 1,605.56 |
Columns are period end dates · fundamentals updated 6 Nov 2026